PointPay, the Blockchain-Based Platform, Launches Solutions to Navigate the Cryptocurrency Market Turbulence

GlobeNewswire

Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032: Visiongain Reports Ltd

Visiongain has published a new report entitled Liposomal Drug Delivery Devices 2022-2032. It includes profiles of Liposomal Drug Delivery Devices and Forecasts Market Segment by Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B), Technology (Stealth Liposome Technology, NonPEGylated Liposome Technology, DepoFoam Liposome Technology), Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), End-user (Hospitals, Diagnostic Cent

Leave a Reply

Your email address will not be published. Required fields are marked *